Cell Reports (Dec 2015)

Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways

  • Lena Seifert,
  • Michael Deutsch,
  • Sara Alothman,
  • Dalia Alqunaibit,
  • Gregor Werba,
  • Mridul Pansari,
  • Matthew Pergamo,
  • Atsuo Ochi,
  • Alejandro Torres-Hernandez,
  • Elliot Levie,
  • Daniel Tippens,
  • Stephanie H. Greco,
  • Shaun Tiwari,
  • Nancy Ngoc Giao Ly,
  • Andrew Eisenthal,
  • Eliza van Heerden,
  • Antonina Avanzi,
  • Rocky Barilla,
  • Constantinos P. Zambirinis,
  • Mauricio Rendon,
  • Donnele Daley,
  • H. Leon Pachter,
  • Cristina Hajdu,
  • George Miller

DOI
https://doi.org/10.1016/j.celrep.2015.10.058
Journal volume & issue
Vol. 13, no. 9
pp. 1909 – 1921

Abstract

Read online

Dectin-1 is a C-type lectin receptor critical in anti-fungal immunity, but Dectin-1 has not been linked to regulation of sterile inflammation or oncogenesis. We found that Dectin-1 expression is upregulated in hepatic fibrosis and liver cancer. However, Dectin-1 deletion exacerbates liver fibro-inflammatory disease and accelerates hepatocarcinogenesis. Mechanistically, we found that Dectin-1 protects against chronic liver disease by suppressing TLR4 signaling in hepatic inflammatory and stellate cells. Accordingly, Dectin-1–/– mice exhibited augmented cytokine production and reduced survival in lipopolysaccharide (LPS)-mediated sepsis, whereas Dectin-1 activation was protective. We showed that Dectin-1 inhibits TLR4 signaling by mitigating TLR4 and CD14 expression, which are regulated by Dectin-1-dependent macrophage colony stimulating factor (M-CSF) expression. Our study suggests that Dectin-1 is an attractive target for experimental therapeutics in hepatic fibrosis and neoplastic transformation. More broadly, our work deciphers critical cross-talk between pattern recognition receptors and implicates a role for Dectin-1 in suppression of sterile inflammation, inflammation-induced oncogenesis, and LPS-mediated sepsis.

Keywords